FORM 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 1, 2007

CELANESE CORPORATION

(Exact Name of Registrant as specified in its charter)


DELAWARE	001-32410	98-0420726

(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1601 West LBJ Freeway, Dallas, Texas 75234-6034

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (972) 443-4000

Not Applicable

(Former name or former address, if changed since last report):

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS


	Item 2.02 Results of Operations and Financial Condition
	Item 7.01 Regulation FD Disclosure
	Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Exhibit Index
EX-23.1: CONSENT OF KPMG LLP
EX-23.2: CONSENT OF KPMG DEUTSCHE TREUHAND-GESELLSCHAFT AKTIENGESELLSCHAFT WIRTSCHAFTSPRUFUNGSGESELLSCHAFT
EX-99.1: PRESS RELEASE
EX-99.2: SLIDE PRESENTATION

Item 2.02 Results of Operations and Financial Condition

On May 1, 2007, Celanese Corporation (the “Company”) issued a press release reporting the financial results for its first quarter 2007. A copy of the press release is attached to this Current Report on Form 8-K (“Current Report”) as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure.

Item 7.01 Regulation FD Disclosure

On May 1, 2007, David N. Weidman, President and Chief Executive Officer of the Company, and John J. Gallagher III, Executive Vice President and Chief Financial Officer of the Company, will make a presentation to investors and analysts via a webcast hosted by the Company at 9:00 a.m. CT. The webcast and slide presentation may be accessed on our website at www.celanese.com under Investor/Presentations & Webcasts. A copy of the slide presentation posted during the webcast is attached to this Current Report as Exhibit 99.2 and is incorporated herein solely for purposes of this Item 7.01 disclosure.

Item 9.01 Financial Statements and Exhibits.


Exhibit Number		Description

23.1		Consent of Independent Registered Public Accounting Firm, KPMG LLP

23.2		Consent of Independent Registered Public Accounting Firm, KPMG Deutsche Treuhand-Gesellschaft Aktieguesellschaft Wirtschaflsprufungsgesellschaft

99.1		Press Release dated May 1, 2007*

99.2		Slide Presentation dated May 1, 2007*


*		In connection with the disclosure set forth in Item 2.02 and Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CELANESE CORPORATION
By:	/s/ Steven M. Sterin
	Name:	Steven M. Sterin
	Title:	Vice President and Corporate Controller

Date: May 1, 2007

Exhibit Index


Exhibit Number		Description

	23.1	Consent of Independent Registered Public Accounting Firm, KPMG LLP

	23.2	Consent of Independent Registered Public Accounting Firm, KPMG Deutsche Treuhand-Gesellschaft Aktieguesellschaft Wirtschaflsprufungsgesellschaft

	99.1	Press Release dated May 1, 2007*

	99.2	Slide Presentation dated May 1, 2007*


*		In connection with the disclosure set forth in Item 2.02 and Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Celanese Corporation:

We consent to the incorporation by reference in the registration statement (No. 333-133934) on Form S-3 of Celanese Corporation and subsidiaries of our report dated February 20, 2007, with respect to the consolidated balance sheets of Celanese Corporation as of December 31, 2006 and 2005, and the related consolidated statements of operations, stockholders’ equity (deficit), and cash flows for the years ended December 31, 2006 and December 31, 2005 and the nine month period ended December 31, 2004, and all related financial statement schedules, management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2006 and the effectiveness of internal control over financial reporting as of December 31, 2006, which reports appear in the December 31, 2006 annual report on Form 10-K of Celanese Corporation.

Our report dated February 20, 2007 contains explanatory paragraphs related to (1) the Company’s adoption of Statement of Accounting Standards No. 123 (revised 2004), “Share-Based Payment,” and Statement of Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans,” both of which were adopted during the year ended December 31, 2006 and (2) the Company’s acquisition of 84.3% of the outstanding stock of Celanese AG in a business combination in April 2004. As a result of the acquisition, the consolidated financial information for the periods after the acquisition is presented on a different cost basis than that for the periods before the acquisition and, therefore, is not comparable.

/s/ KPMG LLP

Dallas, Texas

May 1, 2007

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

The Board of Directors
Celanese Corporation
The Supervisory Board
Celanese AG:

We consent to the incorporation by reference in the registration statement (No. 333-133934) on Form S-3 of Celanese Corporation and subsidiaries of our report dated March 30, 2005, except as to Note 4 (cash flows from discontinued operations), and Note 6 (acetate filament discontinued operations), which are as of March 31, 2006, and Note 6 (penthaerythritol discontinued operations), which is as of February 20, 2007, with respect to the consolidated statements of operations, stockholders’ equity, and cash flows of Celanese AG and subsidiaries for the three-month period ended March 31, 2004, which report appears in the December 31, 2006 annual report on Form 10-K of Celanese Corporation.

Our report dated March 30, 2005, except as to Notes 4 (cash flows from discontinued operations) and 6 (acetate filament discontinued operations), which are as of March 31, 2006, and Note 6 (penthaerythritol discontinued operations), which is as of February 20, 2007 contains an explanatory paragraph that states that Celanese AG and subsidiaries changed from using the last-in, first-out or LIFO method of determining cost of inventories at certain locations to the first-in, first-out or FIFO method as discussed in Note 4 to the consolidated financial statements.

/s/ KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft
Wirtschaftsprüfungsgesellschaft

Frankfurt am Main, Germany

May 1, 2007

Corporate News Release

Celanese Corporation
Investor Relations
1601 West LBJ Freeway
Dallas, Texas 75234-6034

Mark Oberle
Phone: +1 972 443 4464
Fax: +1 972 332 9373
Mark.Oberle@celanese.com

Celanese Corporation Reports Strong First Quarter Results; Raises Outlook for Full Year

First quarter highlights:

	•		Net sales increased 9% to $1,631 million from prior year

	•		Operating profit increased 41% to $239 million

	•		Net earnings increased 72% to $201 million

	•		Operating EBITDA increased 30% to $349 million

	•		Diluted EPS increased 69% to $1.15

	•		Adjusted EPS increased 54% to $0.91 from prior year


	Three Months Ended
	March 31,
(in $ millions, except per share data)	2007		2006

Net sales		1,631		1,498
Operating profit		239		169
Net earnings		201		117
Operating EBITDA ¹		349		269
Diluted EPS — continuing operations	$	0.83	$	0.57
Diluted EPS — Total	$	1.15	$	0.68
Adjusted EPS ¹	$	0.91	$	0.59

¹Non-U.S. GAAP measures. See reconciliation in tables 1 and 6.

Dallas, May 1, 2007: Celanese Corporation (NYSE: CE) today reported strong earnings in the first quarter with net sales of $1,631 million, a 9% increase from the prior year, driven by improved pricing on continued strong demand, volume increases in specialty businesses, and positive currency effects across the company. Net sales included partial quarter results from the company’s recent acquisition of the acetate flake, tow and film business of Acetate Products Limited (APL). Operating profit increased to $239 million from $169 million in the same period last year as operating margins expanded in Chemical Products and Acetate Products. A favorable Canadian methanol production contract and lower selling, general and administrative expenses contributed to the improved performance. Net earnings from continuing operations were $144 million versus $96 million in the first quarter of 2006. All operating results for both

Page 2 of 17

periods shown exclude the discontinued operations of the company’s oxo alcohol business sold in February 2007.

Adjusted earnings per share for the quarter were $0.91 compared to $0.59 in the same period last year. The 2007 adjusted results exclude $17 million in net expense primarily related to costs associated with the exit of an ethylene pipeline venture and certain other expenses which do not reflect underlying operations. Operating EBITDA for the quarter increased to $349 million from $269 million in the prior year period.

“The excellent results in the first quarter reflect the successful execution of our business strategy and the benefits of our balanced geographic and end market presence,” said David Weidman, chairman and chief executive officer. “Our leading global businesses are well-positioned in their respective industries to deliver earnings growth and increased shareholder value.”

Recent Highlights

	•		Announced that its new, world-class GUR^® ultra-high molecular weight polyethylene (UHMW-PE) facility will be located at its integrated chemical complex in Nanjing, China. Also announced approval of new Celstran^® long-fiber reinforced thermoplastic (LFRT) production unit at the Nanjing complex.

	•		Announced a strategic partnership with Accsys Technologies PLC, and its subsidiary Titan Wood, for application of Celanese’s core acetyl products in Accsys’ proprietary Accoya™ wood production process.

	•		Entered a joint venture with Tianjin Shield Fine Chemical Company Limited to manufacture, distribute and sell the vinyl ester of neodecanoic acid, a monomer used to enhance vinyl-based emulsions systems. Commercial production of the joint venture’s 5,000 metric ton plant is expected to begin in late 2007 or early 2008.

	•		Refinanced its senior credit facilities, senior subordinated notes and senior discount notes and repurchased approximately $72 million of its common stock, consistent with the company’s

Page 3 of 17

			strategy to use its strong cash generation to create value for shareholders. Upgraded by Moody’s with affirmed ‘positive’ outlook and outlook revised to ‘positive’ by S&P.

	•		Implemented two governance changes within its board of directors in support of the company’s independent status: the appointment of president and chief executive officer David N. Weidman to chairman, and the election of Mark C. Rohr, president and CEO of Albemarle Corporation, as an independent director.

	•		Announced a new executive retention compensation program linked to shareholder value creation.

	•		Completed the sale of oxo products and derivatives business for a selling price of €480 million.

	•		Discontinued production of methanol and cellulose acetate flake at its manufacturing facility in Edmonton, Alberta, Canada.

First Quarter Segment Overview

Chemical Products

Chemical Products continued to benefit from strong global demand for its differentiated acetyl intermediates products. Net sales, excluding results of the divested oxo alcohol business, rose 6% to $1,078 million compared to the same period last year, primarily due to higher pricing in acetyl intermediates, favorable currency effects, and a beneficial Canadian methanol production contract. Operating profit increased 35% to $181 million compared to the same period last year on higher variable margins. Improved pricing and lower raw material costs drove the increased margins. Operating EBITDA increased 33% to $232 million due to the improved operating profit as well as higher dividend income from the company’s methanol and MTBE cost affiliate in Saudi Arabia.

Ticona Technical Polymers

Innovation and application development in Ticona continued to drive year-over-year volume growth, particularly in the European region. Net sales increased 13% to $262 million compared to the same period last year on increased volumes and positive currency effects, partially offset by lower pricing related to customer and application mix. Operating profit decreased to $36 million from $41 million in the same period last year as higher raw material and energy costs

Page 4 of 17

more than offset the volume increases. Operating EBITDA was $68 million compared to $69 million in the same period last year as performance in the company’s strategic equity investments was unchanged from the prior year.

Acetate Products

Acetate Products delivered strong performance in the quarter. Net sales increased 34% to $223 million compared to the same period last year mainly resulting from the company’s acquisition of the APL business in January 2007 and higher pricing on continued strong demand. Operating profit was $29 million versus $23 million in the same period last year. Higher pricing and lower energy costs more than offset increases in raw materials and temporarily higher manufacturing costs resulting from the previously announced closure of flake production at the company’s Canadian facility in March 2007. The results for the acquired APL business did not materially impact operating profit. Operating EBITDA increased to $37 million compared to $30 million in the same period last year.

Performance Products

Net sales for Performance Products decreased 8% to $45 million for the quarter compared to $49 million in the prior year period as positive currency effects did not offset lower volumes and slightly lower pricing. The lower volumes were primarily related to the company’s exit of its non-core lower margin trade business during the fourth quarter of 2006 and fewer customer product launches this year versus the prior year. Operating profit was $16 million compared to $17 million in the same period last year. Operating EBITDA decreased slightly to $20 million compared to $21 million in the same period last year.

Taxes

The tax rate for adjusted earnings per share was 28% in the first quarters of 2007 and 2006. The U.S. GAAP effective tax rate in 2007 will fluctuate from quarter to quarter given the U.S. GAAP treatment of the recapitalization transaction, described below, as an unusual item which will be accounted for as a discrete transaction in the second quarter. The adjusted tax rate is based on our previous

Page 5 of 17

guidance which did not include this transaction.

Equity and Cost Investments

Earnings from equity investments and dividends from cost investments, which are reflected in the company’s adjusted earnings and operating EBITDA, totaled $33 million in the first quarter, an increase of $8 million from last year on higher dividends from the company’s cost investment in Saudi Arabia, primarily associated with the timing of tax payments. Equity and cost investment dividends, which are included in operating cash flow, increased to $45 million from $24 million last year as the company received increased dividends from both its equity and cost investments, principally due to timing of dividends from the Infraserv equity investments.

Cash Flow

Net debt at the end of the first quarter was $2,374 million, a decrease of $333 million compared to the end of the fourth quarter of 2006. Cash and cash equivalents at the end of the quarter totaled $1,115 million, an increase of $324 million compared to the end of 2006. Cash proceeds from the oxo alcohol business divestiture, net of cash requirements to purchase the remaining share of the EOXO cost investment, were approximately $508 million. Cash requirements related to the acquisition of the APL business were approximately $119 million and the repurchase of Celanese AG shares were approximately $81 million. During the first quarter, the company generated approximately $86 million in cash flow from operations compared to $1 million in the prior year period, excluding cash used by the discontinued oxo alcohol business.

Summary of Recapitalization Transactions

In March 2007, the company announced a comprehensive recapitalization strategy to refinance its debt and repurchase shares. The transaction concluded in April 2007 as the company entered into a new credit facility of approximately $3.7 billion, consisting of $2.8 billion term loans due in 2014, a $650 million revolving credit facility due in 2013 and a $228 million credit linked revolving facility due in 2014. Proceeds from the new credit facility together with available cash were used to retire its $2.4 billion credit facility and redeem approximately $1.4 billion of the senior subordinated notes and senior discount notes. In connection with the refinancing, the company paid approximately $220 million of tender

Page 6 of 17

costs. As a result of the recapitalization, the company lowered its total debt by approximately $200 million.

The company now expects interest expense, excluding one-time items and net of interest income, to be between $205 million and $215 million for 2007 compared to $257 million for 2006.

Through a tender offer, the company also repurchased a total of $72 million of its Series A Common Stock at a purchase price of $30.50 per share. The total repurchase, representing approximately 1.5 percent of its currently outstanding common stock, included shares purchased in the tender offer and on a pro rata basis from investment funds associated with The Blackstone Group, L.P.

In total, the company used approximately $510 million of cash in April 2007 associated with the debt reduction, the closing of the refinancing transaction, and the share repurchase.

“These transactions are a major milestone in our strategy to improve our balance sheet and capture incremental earnings beginning in the second quarter of 2007,” said John J. Gallagher III, executive vice president and chief financial officer. “Through these actions, we have enhanced our operational and strategic flexibility while increasing shareholder value.”

Outlook

Based on the company’s strong performance in the first quarter, the continued strength in its global businesses and the success of its recapitalization efforts, the company raised its 2007 outlook for adjusted earnings per share to between $2.85 and $3.15, with a mid-point of $3.00 per share. The company’s previous guidance range was between $2.70 and $3.00 per share. Lower net interest expense from the refinancing represents an estimated incremental $0.10 per share improvement from the company’s previous guidance. The strong performance in the first quarter will be partially offset by an estimated additional $0.10 per share for the remainder of the year related to the company’s previously announced executive retention program. The company also increased its guidance range for

Page 7 of 17

operating EBITDA to between $1,180 million and $1,250 million from its previous range of between $1,155 million and $1,225 million.

“We remain optimistic about the outlook for the balance of the year based on continued strength in our global businesses,” said Weidman. “Our strengthening portfolio and the substantial progress we have made toward our six-point growth strategy will continue to deliver improved performance and value for our shareholders.”

As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.7 billion in 2006, with over 60% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,900 employees worldwide. For more information on Celanese Corporation, please visit the company’s website at www.celanese.com.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP

This release reflects four performance measures, operating EBITDA, affiliate

Page 8 of 17

EBITDA, adjusted earnings per share, and net debt as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating profit; for adjusted earnings per share is earnings per common share-diluted; and for net debt is total debt.

Use of Non-U.S. GAAP Financial Information

	•		Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.

	•		Affiliate EBITDA, a measure used by management to measure performance of its equity investments, is defined as the proportional operating profit plus the proportional depreciation and amortization of its equity investments. Affiliate EBITDA is not a recognized term under U.S. GAAP and is not meant to be an alternative to operating cash flow of the equity investments. The company has determined that it does not have sufficient ownership for operating control of these investments to consider their results on a consolidated basis. The company believes that investors should consider affiliate EBITDA when determining the equity investments’ overall value in the company.

	•		Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

	•		Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s capital structure. Our management and credit analysts use net debt to evaluate the company’s capital structure and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

Page 9 of 17

Results Unaudited

The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Page 10 of 17

Preliminary Consolidated Statements of Earnings- Unaudited


	Three Months Ended
	March 31,
(in $ millions, except per share data)	2007			2006

Net sales		1,631			1,498
Cost of sales		(1,240	)		(1,160	)

Gross profit		391			338

Selling, general and administrative expenses		(116	)		(138	)
Amortization of Intangibles ¹		(18	)		(14	)
Research and development expenses		(17	)		(17	)
Other charges		(1	)		—
Foreign exchange (loss), net		(1	)		—
Gain on disposition of assets, net		1			—

Operating profit		239			169

Equity in net earnings of affiliates		18			18
Interest expense		(72	)		(71	)
Interest income		14			8
Other income, net		5			6

Earnings from continuing operations before tax and minority interests		204			130

Income tax provision		(60	)		(34	)

Earnings from continuing operations		144			96

Earnings from discontinued operations:
Earnings from operation of discontinued operations		10			32
Gain on disposal of discontinued operations		31			-
Income tax benefit (expense)		16			(11	)

Earnings from discontinued operations		57			21

Net earnings		201			117

Cumulative preferred stock dividend declared		(2	)		(3	)

Net earnings available to common shareholders		199			114


Earnings per common share — basic:
Continuing operations	$	0.89		$	0.59
Discontinued operations		0.36			0.13

Net earnings available to common shareholders	$	1.25		$	0.72

Earnings per common share — diluted:
Continuing operations	$	0.83		$	0.57
Discontinued operations		0.32			0.11

Net earnings available to common shareholders	$	1.15		$	0.68


Weighted average shares — basic		159.3			158.6
Weighted average shares — diluted		174.4			171.5


¹		Customer related intangibles

Page 11 of 17

Selected Preliminary Consolidated Balance Sheets Data — Unaudited


	March 31,		December 31,
(in $ millions)	2007		2006

SELECTED ASSETS DATA
Cash and cash equivalents		1,115		791
Restricted cash		0		46
Receivables:
Trade receivables, net		910		1,001
Other receivables		510		475
Inventories		584		653
Investments		733		763
Property, plant and equipment, net		2,047		2,155

SELECTED LIABILITIES DATA
Short-term borrowings and current installments of long-term debt — third party and affiliates		184		309
Trade payable — third parties and affiliates		731		823
Long-term debt		3,305		3,189
Benefit obligations		907		889

Page 12 of 17

Table 1

Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA -a Non-U.S. GAAP Measure.


	Three Months Ended
	March 31,
(in $ millions)	2007			2006

Net Sales
Chemical Products		1,078			1,015
Technical Polymers Ticona		262			231
Acetate Products		223			167
Performance Products		45			49
Other Activities ¹		59			61
Intersegment eliminations		(36	)		(25	)

Total		1,631			1,498


Operating Profit (Loss)
Chemical Products		181			134
Technical Polymers Ticona		36			41
Acetate Products		29			23
Performance Products		16			17
Other Activities ¹		(23	)		(46	)

Total		239			169


Equity Earnings and Other Income/(Expense) ²
Chemical Products		4			7
Technical Polymers Ticona		14			14
Acetate Products		—			—
Performance Products		—			—
Other Activities ¹		5			3

Total		23			24


Other Charges and Other Adjustments ³
Chemical Products		13			(1	)
Technical Polymers Ticona		1			(2	)
Acetate Products		1			—
Performance Products		—			—
Other Activities ¹		4			13

Total		19			10


Depreciation and Amortization Expense
Chemical Products		34			34
Technical Polymers Ticona		17			16
Acetate Products		7			7
Performance Products		4			4
Other Activities ¹		6			5

Total		68			66


Operating EBITDA
Chemical Products		232			174
Technical Polymers Ticona		68			69
Acetate Products		37			30
Performance Products		20			21
Other Activities ¹		(8	)		(25	)

Total		349			269


¹		Other Activities primarily includes corporate selling, general and administrative expenses and the results from AT Plastics and captive insurance companies.

²		Includes equity earnings from affiliates and other income/(expense), which is primarily dividends from cost investments.

³		Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).

Page 13 of 17

Table 2

Factors Affecting First Quarter 2007 Segment Net Sales Compared to First Quarter 2006


(in percent)	Volume			Price			Currency			Other ¹			Total

Chemical Products		0	%		3	%		3	%		0	%		6	%
Technical Polymers Ticona		9	%		-2	%		5	%		1	%		13	%
Acetate Products		2	%		8	%		0	%		24	%		34	%
Performance Products		-11	%		-1	%		4	%		0	%		-8	%
Total Company		1	%		3	%		3	%		2	%		9	%


¹		Primarily represents net sales from APL (Acetate), AT Plastics and captive insurance companies (Total Company).

Table 3

Cash Flow Information


	Three Months Ended
	March 31,
(in $ millions)	2007			2006

Net cash provided by (used in) operating activities		12			(1	)
Net cash provided by (used in) investing activities		325			(106	)
Net cash provided by (used in) financing activities		(17	)		25
Exchange rate effects on cash		4			4
Cash and cash equivalents at beginning of period		791			390

Cash and cash equivalents at end of period		1,115			312

Page 14 of 17

Table 4

Cash Dividends Received


	Three Months Ended
	March 31,
(in $ millions)	2007		2006

Dividends from equity investments		30		17
Dividends from cost investments		15		7

Total		45		24

Table 5

Net Debt — Reconciliation of a Non-U.S. GAAP Measure


	March 31,		December 31,
(in $ millions)	2007		2006

Short-term borrowings and current installments of long-term debt — third party and affiliates		184		309
Long-term debt		3,305		3,189

Total debt		3,489		3,498
Less: Cash and cash equivalents		1,115		791

Net Debt		2,374		2,707

Page 15 of 17

Table 6

Adjusted Earnings Per Share — Reconciliation of a Non-U.S. GAAP Measure


	Three Months Ended
	March 31,
(in $ millions, except per share data)	2007			2006

Earnings from continuing operations before tax and minority interests		204			130
Non-GAAP Adjustments:
Other charges and other adjustments ¹		19			10
Refinancing costs		(2	)		—

Adjusted earnings from continuing operations before tax and minority interests		221			140
Income tax provision on adjusted earnings ²		(62	)		(39	)

Adjusted earnings from continuing operations		159			101
Earnings from discontinued operations, net of tax and adjustments ³		7			23
Preferred dividends		(2	)		(3	)

Adjusted net earnings available to common shareholders		164			121
Add back: Preferred dividends		2			3

Adjusted net earnings for diluted adjusted EPS		166			124


Diluted shares (millions)

Weighted average shares outstanding		159.3			158.6
Assumed conversion of Preferred Shares		12.0			12.0
Assumed conversion of stock options		3.1			0.9

Total diluted shares		174.4			171.5

Adjusted EPS		0.91			0.59


Earnings per common share from discontinued operations, net of adjustments		0.04			0.13

Adjusted EPS including discontinued operations		0.95			0.72


¹		See Table 7 for details

²		The adjusted U.S. GAAP tax rate for the three months ended March 31, 2007 is 28% based on the forecasted adjusted tax rate for 2007.

³		Does not include gain on sale or tax on gain of sale related to discontinued operations (a total of $50 million).

Page 16 of 17

Table 7

Reconciliation of Other Charges and Other Adjustments

Other Charges:


	Three Months Ended
	March 31,
(in $ millions)	2007		2006

Employee termination benefits		—		2
Plant/office closures		—		(2	)

Total restructuring		—		—
Insurance recoveries associated with plumbing cases				(1	)
Other		1		1

Total		1		-

Other Adjustments: ¹


	Three Months Ended
	March 31,
(in $ millions)	2007		2006

Executive severance & other costs related to Squeeze-Out		1		10
Ethylene Pipeline Exit		10		—
Business Optimization		2		—
Ticona relocation		1		—
Other		4		—

Total		18		10

Total other charges and other adjustments		19		10


¹		These items are included in net earnings but not included in other charges.

Page 17 of 17

Table 8

Equity Affiliate Preliminary Results — Total — Unaudited


	Three Months Ended
(in $ millions)	March 31,
	2007			2006

Net Sales
Ticona Affiliates¹		307			277
Infraserv²		342			321

Total		649			598

Operating Profit
Ticona Affiliates		44			44
Infraserv		17			15

Total		61			59

Depreciation and Amortization
Ticona Affiliates		14			12
Infraserv		19			19

Total		33			31

Affiliate EBITDA³
Ticona Affiliates		58			56
Infraserv		36			34

Total		94			90

Net Income
Ticona Affiliates		30			30
Infraserv		13			12

Total		43			42

Net Debt
Ticona Affiliates		160			29
Infraserv		(14	)		33

Total		146			62

Equity Affiliate Preliminary Results — Celanese Proportional Share — Unaudited⁴


	Three Months Ended
(in $ millions)	March 31,
	2007			2006

Net Sales
Ticona Affiliates		142			128
Infraserv		120			111

Total		262			239

Operating Profit
Ticona Affiliates		21			21
Infraserv		5			4

Total		26			25

Depreciation and Amortization
Ticona Affiliates		6			6
Infraserv		7			7

Total		13			13

Affiliate EBITDA³
Ticona Affiliates		27			26
Infraserv		11			10

Total		38			36

Equity in net earnings of affiliates (as reported on the Income Statement)
Ticona Affiliates		14			14
Infraserv		4			4

Total		18			18

Afilliate EBITDA in excess of Equity in net earnings of affiliates⁵
Ticona Affiliates		13			12
Infraserv		7			6

Total		20			18

Net Debt
Ticona Affiliates		73			11
Infraserv		(5	)		13

Total		68			24


¹		Ticona Affiliates includes PolyPlastics (45% ownership), Korean Engineering Plastics(50%) and Fortron Industries(50%)

²		Infraserv includes Infraserv Entities valued as equity investments (Infraserv Höchst Group — 31% ownership, Infraserv Gendorf — 39% and Infraserv Knapsack 27%)

³		Affiliate EBITDA is the sum of Operating Profit and Depreciation and Amortization

⁴		Calculated as the product of figures from the above table times Celanese ownership percentage

⁵		Product of Celanese proportion of Affiliate EBITDA less Equity in net earnings of affiliates; not included in Celanese operating EBITDA

Table of Contents

Table of Contents

Table of Contents

Table of Contents